SCNI

Profile

Full Name

Scinai Immunotherapeutics Ltd.

Ticker Symbol

SCNI

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Israel

IPO

May 11, 2015

Indexes

Not included

Website

http://www.scinai.com

Employees

31

Key Details

Price

$2.00(+4.17%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$16.00(+60.00% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.00
SCNI price is $2.00

30-Day Relative Volume

1.31
SCNI 30-day relative volume is 1.31

Price Performance

Price Today change

+4.17%
SCNI price is up +4.17% today

Price YTD change

-40.21%
SCNI price is down -40.21% since January 1st

Price 1-year change

-55.36%
SCNI price is down -55.36% year-on-year

Price 3-year change

-98.74%
SCNI price is down -98.74% over the past 3 years

Price Range

Price All-time high

$6200.00
SCNI price is currently -99.97% below its historical high of $6200.00

Price 3-year low

$1.90
SCNI price is currently +5.26% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.71M
SCNI market capitalization is $1.71 million

Market cap 3-year change

-94.24%
SCNI market capitalization is down -94.24% over the past 3 years

Market cap All-time high

$588.67M
SCNI market capitalization is currently -99.71% below its historical high of $588.67 million

Market cap sector rank

6.25%
SCNI market capitalization is higher than 6.25% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+57.93%
SCNI shares outstanding is up +57.93% year-on-year

Shares Outstanding 3-Year Change

+357.86%
SCNI shares outstanding is up +357.86% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.52
SCNI beta is 0.52

200-day SMA

$3.49
SCNI price is currently -42.72% below its 200-day simple moving average

50-day SMA

$3.12
SCNI price is currently -35.90% below its 50-day simple moving average

RSI

22.23
SCNI 14-day relative strength index is 22.23

Volume

1.31
SCNI 30-day relative volume is 1.31

ATR

$0.31
SCNI average true range is $0.31

10-day Historical Volatility

79.99%
SCNI 10-day historical volatility is 79.99%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
SCNI annual revenue value is unknown

Revenue Analysts estimate

-
SCNI annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
SCNI annual revenue 1-year change is unknown

Revenue Sector rank

-
SCNI annual revenue is unknown

EPS

EPS

-$16.00
SCNI annual earnings per share is -$16.00

EPS Analysts estimate

-
SCNI annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+60%
SCNI annual earnings per share is up +60% year-on-year

EPS Sector rank

8.43%
SCNI annual earnings per share is higher than 8.43% of companies in Healthcare sector

Profit

Gross profit

-
SCNI annual gross profit value is unknown

Gross margin

-
SCNI annual gross profit margin value is unknown

Operating profit

-$9.71M
SCNI annual operating income is -$9.71 million

Operating margin

-
SCNI annual operating profit margin value is unknown

Net income

-$6.50M
SCNI annual net profit is -$6.50 million

Net margin

-
SCNI annual net profit margin value is unknown

Expenses

Total expenses

$9.71M
SCNI annual total expenses is $9.71 million

Operating expenses

$9.71M
SCNI annual total operating expenses is $9.71 million

Cost of goods sold

-
SCNI annual cost of goods sold value is unknown

Selling, general & administrative expenses

$4.50M
SCNI annual SGA is $4.50 million

Depreciation and amortization

$514.00K
SCNI annual depreciation & amortization is $514.00 thousand

Interest expense

-
SCNI annual interest expense value is unknown

Income tax

-
SCNI annual income tax value is unknown

EBIT & EBITDA

EBIT

-$9.71M
SCNI annual earnings before interest & taxes is -$9.71 million

EBITDA

-$9.19M
SCNI annual EBITDA is -$9.19 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$17.47M
SCNI annual total assets is $17.47 million

Non current assets

$12.03M
SCNI annual long term assets is $12.03 million

Current assets

$5.45M
SCNI annual total current assets is $5.45 million

Cash and cash equivalents

$4.87M
SCNI annual cash & cash equivalents is $4.87 million

Accounts receivable

-
SCNI annual accounts receivable value is unknown

Inventory

-
SCNI annual inventory value is unknown

Liabilities

Total liabilities

$22.04M
SCNI annual total liabilities is $22.04 million

Long term liabilities

$20.26M
SCNI annual total long term liabilities is $20.26 million

Current liabilities

$1.78M
SCNI annual total current liabilities is $1.78 million

Accounts payable

$535.00K
SCNI annual accounts payable is $535.00 thousand

Debt

Total debt

$20.56M
SCNI annual total debt is $20.56 million

Total debt 1-year change

-4.55%
SCNI annual total debt is down -4.55% year-on-year

Long term debt

$20.16M
SCNI annual long term debt is $20.16 million

Short term debt

$396.00K
SCNI annual short term debt is $396.00 thousand

Equity & Capital

Shareholders equity

-$4.57M
SCNI annual stockholders equity is -$4.57 million

Book value

-$4.57M
SCNI annual book value is -$4.57 million

Retained earnings

-$122.33M
SCNI annual retained earnings is -$122.33 million

Working capital

$3.67M
SCNI annual working capital is $3.67 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$9.38M
SCNI annual cash flow from operations is -$9.38 million

Cash from operations 1-year change

-29.14%
SCNI annual cash flow from operations is down -29.14% year-on-year

Cash from investing

-$637.00K
SCNI annual cash flow from investing activities is -$637.00 thousand

Cash from investing 1-year change

+23.8%
SCNI annual cash flow from investing activities is up +23.8% year-on-year

Cash from financing

$1.09M
SCNI annual cash flow from financing activities is $1.09 million

Cash from financing 1-year change

-83.97%
SCNI annual cash flow from financing activities is down -83.97% year-on-year

CAPEX

CAPEX

-
SCNI annual capital expenditures value is unknown

CAPEX 1-year change

-
SCNI annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$10.02M
SCNI annual free cash flow is -$10.02 million

Free cash flow 1-year change

-23.68%
SCNI annual free cash flow is down -23.68% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
SCNI annual gross profit margin value is unknown

Operating margin

-
SCNI annual operating profit margin value is unknown

Net margin

-
SCNI annual net profit margin value is unknown

ROA & ROE

ROA

-37.20%
SCNI annual return on assets is -37.20%

ROE

142.26%
SCNI annual return on equity is 142.26%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SCNI price to earnings ratio value is unknown

PE ratio Sector rank

-
SCNI price to earnings ratio is unknown

PB Ratio

PB ratio

0.39
SCNI price to book ratio is 0.39

PB ratio Sector rank

26.77%
SCNI price to book ratio is higher than 26.77% of companies in Healthcare sector

PS Ratio

PS ratio

3.77
SCNI price to sales ratio is 3.77

PS ratio Sector rank

59.23%
SCNI price to sales ratio is higher than 59.23% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.90M
SCNI enterprise value is $1.90 million

Enterprise value Sector rank

15.52%
SCNI enterprise value is higher than 15.52% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.24
SCNI EV/EBITDA is 0.24

EV/EBITDA Sector rank

69.57%
SCNI EV/EBITDA is higher than 69.57% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.06
SCNI annual current ratio is 3.06

Quick ratio

-
SCNI annual quick ratio value is unknown

Leverage

Debt to equity

-4.50
SCNI annual debt to equity ratio is -4.50

Interest coverage ratio

-
SCNI annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
SCNI piotroski f-score value is unknown

Altman Z-Score

-
SCNI altman z-score value is unknown

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

AKAN logo
Akanda (AKAN)
Polyrizon (PLRZ)
HSDT logo
Helius Medical Technologies (HSDT)
ONCT logo
Oncternal Therapeutics (ONCT)
AVGR logo
Avinger (AVGR)
Syra Health Corp Class A (SYRA)
ZVSA logo
ZyVersa Therapeutics (ZVSA)
CERO logo
CERo Therapeutics Holdings (CERO)
ENTO logo
Entero Therapeutics (ENTO)
  • What is the ticker symbol for Scinai Immunotherapeutics?
  • Does Scinai Immunotherapeutics pay dividends?
  • What sector is Scinai Immunotherapeutics in?
  • What industry is Scinai Immunotherapeutics in?
  • What country is Scinai Immunotherapeutics based in?
  • When did Scinai Immunotherapeutics go public?
  • Is Scinai Immunotherapeutics in the S&P 500?
  • Is Scinai Immunotherapeutics in the NASDAQ 100?
  • Is Scinai Immunotherapeutics in the Dow Jones?
  • When was Scinai Immunotherapeutics's last earnings report?
  • When does Scinai Immunotherapeutics report earnings?

What is the ticker symbol for Scinai Immunotherapeutics?

The ticker symbol for Scinai Immunotherapeutics is NASDAQ:SCNI

Does Scinai Immunotherapeutics pay dividends?

No, Scinai Immunotherapeutics does not pay dividends

What sector is Scinai Immunotherapeutics in?

Scinai Immunotherapeutics is in the Healthcare sector

What industry is Scinai Immunotherapeutics in?

Scinai Immunotherapeutics is in the Biotechnology industry

What country is Scinai Immunotherapeutics based in?

Scinai Immunotherapeutics is headquartered in Israel

When did Scinai Immunotherapeutics go public?

Scinai Immunotherapeutics's initial public offering (IPO) was on May 11, 2015

Is Scinai Immunotherapeutics in the S&P 500?

No, Scinai Immunotherapeutics is not included in the S&P 500 index

Is Scinai Immunotherapeutics in the NASDAQ 100?

No, Scinai Immunotherapeutics is not included in the NASDAQ 100 index

Is Scinai Immunotherapeutics in the Dow Jones?

No, Scinai Immunotherapeutics is not included in the Dow Jones index

When was Scinai Immunotherapeutics's last earnings report?

Scinai Immunotherapeutics's most recent earnings report was on Nov 22, 2024

When does Scinai Immunotherapeutics report earnings?

The next expected earnings date for Scinai Immunotherapeutics is May 15, 2025
On this page